ABSTRACT
INTRODUCTION
Benzo(a)pyrene (BaP) is a carcinogen produced by organic material combustion. Workers in gas generation and steel plants and individuals engaged in aluminum reduction and roofing have higher cancer risks associated with long-term exposure to various polycyclic aromatic hydrocarbons including BaP (1) . After diffusing into a cell, BaP binds with an aryl hydrocarbon receptor (AhR), translocates into the cell's nuclei, and transactivates the cytochrome P450 1A1 (CYP1A1) gene (2) (3) (4) . A metabolic BaP product known as BaP-7,8-diol 9,10-epoxide (BPDE) is capable of forming DNA adducts and triggering mutagenesis (5) .
Glycine N-methyltransferase (GNMT; EC2.1.1.20), a protein with multiple functions, affects genetic stability by (a) regulating the ratio of S-adenosylmethionine (SAM) to S-adenosylhomocystine and (b) binding to folate (6, 7) . We have reported previously (8, 9) on diminished GNMT expression levels in both human hepatocellular carcinoma cell lines and tumor tissues. In previous projects, we localized the human GNMT gene to the 6p12 chromosomal region and characterized its polymorphism (10, 11) . Genotypic analyses of several human GNMT gene polymorphisms showed a loss of heterozygosity in 36 -47% of the genetic markers in hepatocellular carcinoma tissues (11) . In this study, we evaluated the effects of GNMT on liver cells treated with BaP in a transient transfection system or with stably expressed clones, based on the identification of GNMT as a 4 S polycyclic aromatic hydrocarbon-binding protein (12) . We also used automated docking with a Lamarckian genetic algorithm (LGA) to elucidate GNMT-BaP interaction. In light of results showing a BaP binding preference for the SAM-binding domain of GNMT, we expanded our BaP docking experiments to include other SAM-dependent methyltransferases; our results show that BaP interacts readily with DNA methyltransferases that use cytosine as a target atom.
MATERIALS AND METHODS
Cell Lines and Culture. Two hepatocellular carcinoma cell lines [Huh7 (13) and HA22T/VGH (14) ] and one human hepatoblastoma cell line [HepG2 (15) ] were used in this study. Cells were cultured in DMEM (GIBCO BRL, Grand Island, NY) with 10% heat-inactivated fetal bovine serum (HyClone, Logan, UT), penicillin (100 IU/ml), streptomycin (100 g/ml), nonessential amino acids (0.1 mM), fungizone (2.5 mg/ml), and L-glutamine (2 mM) in a humidified incubator with 5% CO 2 .
Construction of pGNMT, pGNMT-antisense, and pGNMT-His-short Plasmids. To construct plasmid pGNMT containing the cytomegalovirus (CMV) promoter and GNMT cDNA fragment, we used plasmid-pFLAG-CMV-5 (Kodak, Rochester, NY) as a vector and the pBluescript-GNMT-9-1-2 phagemid (8) as the PCR template for generating the insert. A 0.9-kb DNA fragment containing the GNMT cDNA sequence and restriction enzyme sites on both ends was amplified. All PCR conditions were as recommended by the manufacturer (Perkin-Elmer, Norwalk, CT), with two exceptions (2 mM MgCl 2 and 150 nM primer). Twenty amplification cycles were performed using Perkin-Elmer Amplitaq Gold Taq DNA polymerase with DNA Thermal Cycler. Each PCR cycle entailed a primer annealing step at 60°C for 30 s and an extension step at 72°C for 30 s. The upstream primer (5Ј-gcggaattcATGGT-GGACAGCGTGTAC-3Ј) included a 3-bp "clamp" (gcg) at the 5Ј end followed by a single restriction enzyme site (EcoRI) and the GNMT cDNA sequence. The downstream primer (5Ј-gcggaattcGTCTGTCCTCTTGAG-CAC-3Ј) contained a similar structural motif as the upstream primer; however, it consisted of a negative strand sequence from the terminal region of the GNMT cDNA. Immediately after amplification, SDS (0.1%) and EDTA (5 mM) were added to the PCR reaction; DNA was precipitated with 2.5 M ammonium acetate and 70% ethanol. After digestion with EcoRI, the DNA fragment was isolated by elution from the agarose gel and ligated to EcoRIdigested pFLAG-CMV-5.
We used two primers (F1, 5Ј-gcggaattcATGGTGGACAGCGTGTAC-3; R1, 5Ј-gcggaattcTGTACTCGGCGGTGCGGC-3) to construct an antisense-GNMT plasmid (pGNMT-antisense) for amplifying a 136-bp DNA fragment from phagemid pBluescript-GNMT-9-1-2 (8) . The fragment contained an antisense sequence spanning the GNMT translational starting site and two restriction enzyme sites (EcoRI and BamHI) at its terminals. Cloning procedures were similar to those described for pGNMT.
To express the GNMT recombinant protein (RP) in Escherichia coli, we constructed plasmid pGNMT-His-short. The large S-tag DNA fragment was excised from the pGNMT-His (9) using EcoRI and NdeI restriction enzymes (Stratagene, La Jolla, CA); the resulting plasmid DNA was religated after a Klenow reaction. Plasmid DNA sequences were confirmed with a DNA sequencer equipped with a dye terminator cycle sequencing core kit (Applied Biosystems Model 373A, Version 1.0.2; Applied Biosystems, Foster City, CA).
GNMT RP Expression and Purification. pGNMT-His-short was used to transform the E. coli BL21 bacteria used for isopropyl-1-thio-␤-D-galactopyranoside induction (induction time, 3 h; bacterial culture absorbance, 0.6 -0.7). GNMT RP purification was performed using a Ni 2ϩ -charged histidine-binding resin column according to the manufacturer's guidelines (Novagen, Madison, WI). RP concentration was measured with a BCA protein assay (Pierce, Rockford, IL); purity was tested by running samples on a 12.5% SDSpolyacrylamide mini-gel (Bio-Rad Laboratories, Richmond, CA).
Transfection. All plasmid DNA samples were prepared using Qiagen mega kits (Hilden, Germany). Standard calcium phosphate coprecipitation methodology (16) was used to transfect cultured cells from various liver cancer cell lines with plasmid DNA. Forty-eight h after transfection, cells were treated with different concentrations (1-10 M) of BaP (Sigma-Aldrich, Steinheim, Germany) dissolved in DMSO (Nacalaitesque, Osaka, Japan) for 16 h. Treated cells were subjected to either indirect immunofluorescent antibody assay or 32 P postlabeling. To produce a negative control, 0.1% DMSO was added to the cell culture.
Establishing Stable Clones Expressing GNMT. Using calcium phosphate methodology, HepG2 cells were cotransfected with pGNMT and pTK-Hyg (Clontech, Palo Alto, CA) plasmid DNAs. Cells were placed in a selection medium containing 300 g/ml hygromycin (17) . More than 12 clones were selected, and GNMT expression was analyzed with a Western blot (WB) assay using cell lysate collected from each clone. Among them, SCG2--1-1 and SCG2-1-11 were chosen for further study based on their expression level of GNMT. SCG2-neg, a stable clone selected from HepG2 cells cotransfected with pFLAG-CMV-5 and pTK-Hyg plasmids, was also used as a control in this study.
Indirect Immunofluorescent Antibody Assay. Cultured HA22T/VGH or Huh7 cells were placed on cover slides, treated with 10 M BaP or 0.1% DMSO, fixed with solution I (4% paraformaldehyde and 400 mM sucrose in PBS) at 37°C for 30 min, fixed with solution II (fixing solution I plus 0.5% Triton X-100) at room temperature for 15 min, and fixed with blocking buffer (0.5% BSA in PBS) at room temperature for 1 h. After washing with PBS, the slides were allowed to react with various primary antibodies at 4°C overnight. The two antibodies were anti-FLAG monoclonal antibody (1:500 dilution; Kodak) and rabbit anti-GNMT antiserum-R4 (1:200 dilution; Ref. 12). FITCconjugated antimouse IgG and tetramethylrhodamine isothiocyanate-conjugated antirabbit IgG (Sigma-Aldrich) were used as secondary antibodies. After four washes with PBS, slides were mounted and observed using a confocal fluorescence microscope (TCS-NT, Hilden, Germany). DNA was stained with Hoechst H33258 (Sigma-Aldrich) to localize cell nuclei.
Generating Adenovirus Carrying GNMT cDNA (Ad-GNMT). To construct a GMNT recombinant adenovirus controlled by a CMV promoter, pGEX-GNMT (9) was digested with XhoI (filled-in) and BamHI before insertion into the XbaI (filled-in) and BamHI sites of pBluescript SK(Ϫ) (Stratagene). GNMT cDNA was also cloned into the HindIII and NotI sites of pAdE1CMV/pA (18), a shuttle vector containing the left arm of a virus genome, to generate pXCMV-GNMT. A recombinant adenovirus appeared within 7-12 days after the cotransfection of pXCMV-GNMT and pJM17 (18) into 293 cells. Individual virus clones were isolated and identified using PCR with primer sets specific to the adenoviral sequence (18) , the insertion flanking regions (18) , and the GNMT cDNA (8) . Virus titer was determined via the plaque assay method described above (18) .
32 P Postlabeling and Five-Dimensional TLC for Quantifying BPDE-DNA Adducts. We used SCG2 cells and hepatocellular carcinoma cell lines transiently transfected with pGNMT plasmid DNA for 48 h for our experiments. DNA was extracted from cells treated with 10 M BaP or 0.1% DMSO (control) for 16 h (19) and digested with micrococcal endonuclease and spleen phosphodiesterase in succinate buffer (20 mM sodium succinate and 10 mM CaCl 2 ) for 3 h at 37°C. The resulting 3Ј nucleotides were further extracted twice with butanol solution and labeled with [␥-
32 P]ATP with T4 kinase in labeling buffer at 38°C for 30 min. Five-dimensional TLC was used to elucidate labeled DNA adducts (20) . Relative adduct level was calculated as cpm in adducted nucleotides/(cpm in total nucleotides ϫ dilution).
Aryl Hydrocarbon Hydroxylase Assay. To measure CYP1A1 enzyme activity, approximately 100 g of cellular homogenates were incubated with reactive solution (100 mM HEPES, 0.4 mM NADPH, 1 mM MgCl 2 , and 20 M BaP) at 37°C for 10 min. Supernatant protein concentrations were determined using a Bio-Rad protein assay kit (Hercules, CA). Reactions were stopped by the addition of acetone; extraction was performed with hexane and 1N NaOH. NaOH fractions were read on a spectrofluorometer (Hitahi Instrument F4500) with excitation and emission wavelengths of 396 nm and 522 nm, respectively. Reaction product (3-hydroxy-BaP) concentrations were calculated by comparison with a standard; procedural details are given in Ref. 21 . WB Assay. WB was used to detect GNMT in transfected cells or SCG2 clones. Anti-GNMT monoclonal antibody 14-1 was used to detect GNMT (9) . A detailed description of WB procedures is presented in Ref. 22 .
LGA Dockings.
LGA was used to elucidate interaction sites between BaP and various forms of GNMT. Autodock 3.0 software was used to identify the most favorable ligand binding interactions. We empirically determined van der Waals hydrogen bonding, hydrophobic desolvations, and electrostatic and torsional free energy to reproduce ligand-protein binding free energies (23) . We used X-ray crystallography data from rat GNMT for docking due to its 91% amino acid sequence homology with human GNMT (24, 25) . We analyzed interactions between BaP and methyltransferase-1VID (26), 1HMY (27) , 2ADM (28), 1DCT (29) , 1BOO (30), 2DPM (31), 1EG2 (32) , and 1G55 (33) . Parameters were as follows: 10 runs; a population size of 50; and a runtermination criterion of a maximum of 27,000 generations or 2.5 ϫ 10 5 energy evaluations, whichever came first. A root mean square deviation conformational clustering tolerance of 0.5 Å was calculated from the ligand's crystallographic coordinates. Procedural details are available in Ref. 34 . GNMT Enzyme Activity Assay. GNMT RP purified from a Ni 2ϩ -charged histidine-binding resin column was used for an enzyme activity assay. GNMT RP (10 mg) was mixed with 10, 50, or 100 M BaP or DMSO solvent (control) at room temperature for 60 min before treatment with 100 l of 100 mM Tris buffer (pH 7.4) containing 50 mM glycine, 0.23 mM SAM, and 2.16 M
S-adenosyl-L-[methyl-
3 H]methionine (76.4 Ci/mmol). After incubation at 37°C for 30 min, individual reactions were terminated by the addition of a 50-l mixture of 10% trichloroacetic acid and 5% activated charcoal. Each reaction was performed in triplicate. This procedure has been described in detail by Cook and Wagner (35) .
RESULTS

GNMT Nuclear Translocation Was Induced by BaP in Both
HA22T/VGH and Huh7 Cells. GNMT was expressed in the cytoplasm of HA22T/VGH cells 48 h after transfection with pGNMT DNA (double indirect immunofluorescent antibody assay with both rabbit anti-GNMT antiserum and mouse anti-FLAG monoclonal antibody; Fig. 1, A and B) . Similar results were noted in control Huh7 cells treated with DMSO solvent (Fig. 1, C and D) . In contrast, GNMT proteins were only partly translocated into the nuclei of Huh7 cells treated with 10 M BaP for 16 h (Fig. 1, E and F) . DNA was stained with Hoechst H33258 to localize cell nuclei (Fig. 1, D and F) .
Inhibitory Effect of GNMT on BPDE-DNA Adduct Formation. 32 P postlabeling and five-dimensional TLC were used to quantify BPDE-DNA adduct formation. After treatment with 10 M BaP for 16 h, BPDE-DNA adduct formation in HepG2, Huh7, and HA22T/ VGH cells transfected with pGNMT decreased 52.8%, 13.5%, and 20.7%, respectively, compared with cells transfected with the vector plasmid ( Table 1) . Because the inhibitory effect of GNMT on BPDE-DNA adduct formation was strongest in the HepG2 cells, we used that cell line as the target in subsequent experiments. HepG2 cell DNA transfection efficiency was approximately 30%. In addition to pGNMT, a plasmid containing an antisense GNMT sequence was constructed for the purpose of verifying the specificity of the GNMT effect. After BaP treatment, a 34.1% decrease was noted in BPDE adducts formed in pGNMT-transfected cells compared with cells transfected with the vector control plasmid (Fig. 2A, 3 and 4) . In contrast, a 29.2% increase in BPDE adducts was noted in HepG2 cells transfected with pGNMT-antisense ( Fig. 2A, 5) . Quantities of BPDE-DNA adducts formed in cells transfected with equal amounts (20 g) of pGNMT and pGNMT-antisense were approximately equal to those formed in the vector control cells (Fig. 2A, 6) . GNMT expression in different transfection experiments and the effects of antisense GNMT cDNA plasmid construct (pGNMT-antisense) were verified by WB assays with mouse anti-GNMT monoclonal antibody. As shown in Lane 4 of Fig. 2B , GNMT was not detected in the lysates of cells transfected with equal amounts of pGNMT and pGNMT-antisense.
We used two stable clones (SCG2-1-1 and SCG2-1-11) from HepG2 cells transfected with pGNMT in the same experiments described above. Results from a Northern blot assay indicate that copy numbers (per cell) of GNMT cDNA present in SCG2-1-1 and SCG2-1-11 cells were 3 and 1, respectively (data not shown). Results from a WB assay showed that the GNMT expression level in the SCG2-1-1 cells was nearly three times that in the SCG2-1-11 cells (Fig. 2D,  Lanes 2 and 3) . After treating the SCG2-1-1 and SCG2-1-11 cells with 1 or 10 M BaP, BPDE-DNA adduct formation inhibition was proportional to GNMT-expression levels under both treatment conditions (Fig. 2C) .
We performed the same experiment using an adenovirus carrying GNMT cDNA (Ad-GNMT). A positive linear relationship was noted between the multiplicities of infection (MOIs) of the Ad-GNMT and BPDE-DNA-adduct formation inhibition (Fig. 3) . Compared with Ad-GFP-control-infected cells, the Ad-GNMT MOIs increased from 100 to 250 to 1000, and BPDE-DNA adduct formation decreased 19.5%, 36.6%, and 61.8%, respectively (Fig. 3A) . GNMT expression levels in HepG2 cells infected with MOI ϭ 100 of Ad-GFP control and MOI ϭ 100, 250, and 1000 of Ad-GNMT were analyzed by WB; results are shown in Fig. 3B, Lanes 1-4 .
GNMT Effect on CYP1A1 Enzyme Activity Induced by BaP. SCG2-1-1 and SCG2-neg cells were treated with varying concentrations of BaP for 16 h before using aryl hydrocarbon hydroxylase assay to measure their cellular CYP1A1 enzyme activity. CYP1A1 activity in cells treated with 3, 6, and 9 M BaP was 24.5, 41.5 and 71.3 pmol/mg/min for SCG2-neg cells, respectively, and 20.1, 27.7, and 36.2 pmol/mg/min for SCG2-1-1 cells, respectively (Fig. 4) . For cells treated with 9 M BaP, this represents a 45% reduction in CYP1A1 enzyme activity in GNMT-expressing cells (i.e., SCG2-1-1) compared with SCG2-neg cells.
Modeling GNMT-BaP Interaction. We used a LGA to predict physical GNMT-BaP interaction. Again, due to its 91% homology with human GNMT proteins, rat GNMT X-ray crystallography was used for the BaP docking experiments. As shown in Fig. 5, A and B, we found that BaP binds with both dimeric (yellow) and tetrameric (cyan) forms of GNMT but that it prefers binding with the dimeric form (Protein Data Bank code 1D2C). This cluster is located at the intersection of the SAM-and S-adenosylhomocystine-binding sites (Table 2 ; Fig. 5B ). The low (Ϫ9.10 kcal/mol) binding energy between the dimeric form of GNMT and BaP suggests that BaP may displace (Table 2) . Accordingly, several GNMT amino acid residues (including Thr 37 (Fig. 5C) .
BaP-Induced Inhibition of GNMT Enzyme Activity. Based on the inference that BaP can bind with GNMT, we studied the potential effects of BaP on GNMT enzyme activity by constructing plasmid pGNMT-His-Short to express a His-tag-GNMT RP in E. coli. GNMT RP purified from a Ni 2ϩ -charged histidine-binding resin column was used for our analysis. As shown in Fig. 6 , GNMT enzyme activity from reactions containing 10 and 50 M BaP decreased 44% and 62%, respectively, compared with the DMSO control.
DISCUSSION
We used an indirect immunofluorescent antibody assay to demonstrate the power of BaP to induce the nuclear translocation of GNMT. Our results show that GNMT not only inhibits BPDE-DNA adduct formation but also down-regulates CYP1A1 enzyme activity; conversely, BaP also inhibits GNMT enzyme activity. Finally, we used a docking experiment to show the exact location of BaP-GNMT interaction. These results represent a novel finding of a cellular defense mechanism against potentially damaging forms of exposure. We confirmed the inhibition of BPDE-DNA adduct formation by GNMT via transient transfection, stable clone selection, and adenovirus infection systems, with consistent results throughout. An antisense construct for GNMT cDNA was used to demonstrate interaction specificity ( Fig.  2A) , and WB assays were used to monitor GNMT expression levels in various gene transfer experiment sets. The dose-dependent inhibitory effect of GNMT on BPDE-DNA adduct formation was further elaborated with HepG2 stable clones and a recombinant adenovirus carrying GNMT cDNA (Figs. 2C and 3A) .
Many polycyclic aromatic hydrocarbons induce cytochrome P450 expression through an AhR-dependent pathway (36) . After diffusing into a cell, BaP binds with AhR and translocates into the nuclei, where BaP-AhR heterodimers form complexes with Ah receptor nuclear translocator (Arnt) proteins (2) . The BaP-AhR-Arnt complexes then transactivate the CYP1A1 gene via interaction with its xenobiotic responsive element in the promoter region (37) . In addition to the inhibition of BPDE-DNA adduct formation, our results show that GNMT is capable of reducing CYP1A1 enzyme activity induced by BaP (Fig. 4) . Foussat et al. (38) used AhR-deficient transgenic mice to demonstrate that GNMT is not a transcriptional activator of the CYP1A1 gene (38) . Preliminary data from our real-time PCR analysis showed that after BaP treatment, CYP1A1 gene expression was reduced by approximately 20% in SCG2-1-1 cells compared with HepG2 cells. 5 Previous research has shown that the tetrameric form of rat GNMT acts as an enzyme and that the dimeric form of rat GNMT is capable of binding with polycyclic aromatic hydrocarbons (39) . In this study, we used LGA and a scoring function for estimating binding-related free energy change to locate possible sites for interactions between BaP and various forms of GNMT; we used X-ray crystallography data for rat GNMT for this purpose. Our results indicate that (a) the BaP-binding domain is located at the substrate (SAM)-binding site of GNMT and (b) BaP prefers binding with the dimeric form of GNMT. The R175K mutant form of the GNMT tetramer (Protein Data Bank code 1D2G) was used to demonstrate that although the R/K residue is near the binding site (ϳ5 Å from the SAM position), it exerts practically no effect on GNMT-BaP cluster formation (Table 2 ). In comparison, the presence of an acetate ion favors the formation of the second preferred cluster in GNMT-SAM binding in the 1XVA crystal structure (Table 2, final entry) . It has been demonstrated that of various search systems, the LGA method is the most likely to locate crystallographic structures (23) . Heavily populated clusters usually correspond to crystallographically determined positions that show 0.2-0.8 Å root mean square differences from the crystal structures. For most ligands, our docking simulation predicted single binding modes that matched crystallographic binding modes within 1.0 Å root mean square deviation (23) . We therefore suggest that the LGA is a reliable method for predicting the bound conformation of a ligand to its macromolecular target. BaP-GNMT interaction was also confirmed by a functional assay showing that GNMT enzyme activity was reduced nearly 50% in the presence of BaP (Fig. 6) .
Because (Table 3) . It is interesting to note that the target atom of all of the BaP-preferred DNA methyltransferases is cytosine and not adenine (40) . To our knowledge, this is the first evidence suggesting that an environmental carcinogen such as BaP has the potential to interact with different DNA methyltransferases. In light of evidence showing that the induction of GNMT enzyme activity by all-trans-retinoic acid causes DNA hypomethylation in rat hepatocytes (22) , we suggest that BaP may affect DNA methylation via interactions with DNA methyltransferase and GNMT and thus contribute to a carcinogenic pathway. e BaP displaces the SAM position. f RMSD ϭ 2.70 Å. A second cluster (n ϭ 5) corresponds to the known crystal structure at an RMSD of 0.68 Å and a mean energy of Ϫ8.80 kcal/mol. Note the nearby location of an acetate ion that might serve to stabilize the second cluster. 
